The adherens junction-associated protein 1 is a negative transcriptional regulator of MAGEA2, which potentiates temozolomide-induced apoptosis in GBM

International Journal of Oncology
Liang ZengDavid Cory Adamson

Abstract

Previous studies identified the frequent loss of adherens junction-associated protein 1 (AJAP1) expression in glioblastoma (GBM) and its correlation with worse survival. AJAP1 may suppress glioma cell migration, which plays an important role in tumor progression in malignant gliomas such as GBM. However, the role of AJAP1 in cell cycle arrest or apoptosis and resistance to chemotherapy remains unclear. Based on microarray screening results, quantitative PCR and luciferase plasmid reporter constructs were used to evaluate the possible regulatory role of AJAP1 on MAGEA2 expression and function. Cell death assays, TUNEL and other markers of apoptosis were utilized to detect cell apoptosis. Restoration of AJAP1 expression in glioma cells was analyzed after temozolomide exposure. AJAP1 suppressed the expression of MAGEA2 and inhibited the transcriptional activity of MAGEA2 in glioma cells. As AJAP1 expression decreased MAGEA2 protein expression apoptosis increased moderately. Consistent with increased cell death, the induced loss of MAGEA2 expression correlated with increased caspase 3/7 activity, BCL2/BAX ratio and TUNEL signal. AJAP1 expression enhanced cell death in the presence of temozolomide. This study suggests AJAP1 may also...Continue Reading

References

May 10, 2001·Current Opinion in Cell Biology·K M RyanK H Vousden
Dec 7, 2002·International Journal of Clinical Pharmacology and Therapeutics·B Kaina, M Christmann
Apr 17, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A GieseM Westphal
Nov 5, 2003·Molecular Biology of the Cell·Sanita BhartiAnna Starzinski-Powitz
Jan 2, 2004·The American Journal of Psychiatry·L Fredrik JarskogJohn H Gilmore
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Aug 16, 2005·Current Opinion in Cell Biology·Jack Lilien, Janne Balsamo
Nov 19, 2005·Science·Maria Domenica CastelloneJ Silvio Gutkind
Dec 21, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Markus BredelBranimir I Sikic
Jul 19, 2006·Proceedings of the National Academy of Sciences of the United States of America·Martin MonteClaudio Schneider
Feb 3, 2007·Molecular Biology of the Cell·Alexander SchreinerAnna Starzinski-Powitz
Nov 27, 2007·Expert Opinion on Pharmacotherapy·Tomokazu AokiMasao Matsutani
Mar 13, 2008·Structure·Cara J Gottardi, Mark Peifer
Mar 13, 2009·American Journal of Physiology. Cell Physiology·Olga Prokopenko, Oleg Mirochnitchenko
Jul 18, 2009·Molecular Cancer Research : MCR·Guido Frosina
Aug 12, 2009·Expert Opinion on Pharmacotherapy·Maurizio SalvatiAlessandro Frati
Nov 19, 2009·Cancer Research·Lonneke A M GravendeelPim J French
Sep 28, 2010·The Journal of Biological Chemistry·Claudia R OlivaCorinne E Griguer
Dec 24, 2010·Neuro-oncology·Shyamal D WeeraratneYoon-Jae Cho
Mar 23, 2011·Archives of Otolaryngology--head & Neck Surgery·Chad A GlazerJoseph A Califano
May 12, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sheetal BhanJoseph A Califano
May 14, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tricia NardielloHearn Jay Cho
Jan 14, 2012·Molecular Cancer Research : MCR·Ningjing LinDavid Cory Adamson
Nov 23, 2012·Cancer Research·Kai-Oliver HenrichFrank Westermann

❮ Previous
Next ❯

Citations

Jun 7, 2019·Journal of Experimental & Clinical Cancer Research : CR·Cong XuYun Niu
May 9, 2014·International Journal of Oncology·Liang ZengDavid Cory Adamson
Sep 24, 2015·International Journal of Oncology·Haruyoshi TanakaYasuhiro Kodera
Oct 17, 2021·Journal of Clinical Laboratory Analysis·Rubing LiFeng Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adherens Junctions

An adherens junction is defined as a cell junction whose cytoplasmic face is linked to the actin cytoskeleton. They can appear as bands encircling the cell (zonula adherens) or as spots of attachment to the extracellular matrix (adhesion plaques). Adherens junctions uniquely disassemble in uterine epithelial cells to allow the blastocyst to penetrate between epithelial cells. Discover the latest research on adherens junctions here.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.